<DOC>
	<DOCNO>NCT01538628</DOCNO>
	<brief_summary>The purpose study evaluate safety SpaceOAR System hydrogel injected rectum prostate men undergo radiation therapy ( IG-IMRT ) evaluate whether use SpaceOAR hydrogel result reduction radiation exposure anterior rectum .</brief_summary>
	<brief_title>SpaceOAR System Pivotal Study</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Subjects great 18 year old Subjects must pathologically confirm invasive adenocarcinoma prostate must plan undergo IMRT Subjects must clinical stage T1 T2 determine biopsy take within 6 month baseline/screening visit Gleason Score less equal 7 Subjects Screening/Baseline laboratory test must meet follow laboratory value criterion : PSA le equal 20 ng/mL , hematocrit great 30 % , serum creatinine le 2.0 mg/dl , serum AST ALT less 2.5 time upper limit institution normal , serum bilirubin le 2.0 mg/dl Subject authorize representative , informed nature study provide write informed consent , approve appropriate Institutional Review Board ( IRB ) respective clinical site Prostate great 80cc document within 3 month precede Screening/Baseline visit Subjects extracapsular extension prostate cancer , great 50 % number biopsy core positive cancer , metastatic disease , ongoing cancer treat study , subject pelvic lymph node radiotherapy plan Subjects prior invasive malignancy ( except nonmelanomatous skin cancer ) unless subject disease free minimum 5 year . Subjects indicate androgen deprivation therapy treat androgen therapy within prior 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Spacer</keyword>
</DOC>